3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
7
Gastrointestinal
7
Endocrine
7
Sarcoma
2
Lymphoid
1
CNS
1
Conditions
Lymphoma
725
Lymphoma, Non-Hodgkin
659
Precursor Cell Lymphoblastic Leukemia-Lymphoma
585
Leukemia, Lymphocytic, Chronic, B-Cell
555
Lymphoma, Large B-Cell, Diffuse
440
Lymphoma, Follicular
418
Lymphoma, Mantle-Cell
345
Burkitt Lymphoma
306
Leukemia
304
Leukemia, Myeloid, Acute
298
Hodgkin Disease
294
Lymphoma, B-Cell
281
Lymphoma, B-Cell, Marginal Zone
267
Recurrence
246
Multiple Myeloma
205
Neoplasms
200
Myelodysplastic Syndromes
171
Lymphoma, T-Cell, Cutaneous
171
Lymphoma, Large-Cell, Immunoblastic
160
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
159
Waldenstrom Macroglobulinemia
146
Lymphoma, Large-Cell, Anaplastic
142
Mycosis Fungoides
132
Sezary Syndrome
119
Immunoblastic Lymphadenopathy
108
Blast Crisis
92
Hematologic Neoplasms
91
Lymphoma, T-Cell, Peripheral
86
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
86
Lymphoma, T-Cell
82
Interventions
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Gastro-enteropancreatic neuroendocrine tumor
×
Lymphoid
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled